PDCD1 and obesity disorder: Its establishment in the gut has been documented to offer a safeguard against obesity stemming from dietary factors [52, 53], promote mucosal wound healing [54], induce adaptive immune responses during intestinal stabilization [32], and enhance antitumor responses during anti-PD-1 immunotherapy [10], which is consistent with our research results.